Vivus weight loss drug faces safety questions
Tuesday, July 13, 2010 - 09:49
in Health & Medicine
(AP) -- Vivus Inc.'s potential weight loss drug Qnexa will likely draw scrutiny over nervous system and psychiatric side effects from a panel of Food and Drug Administration experts this week.